1. Home
  2. CRL
  3. CRL News

Latest Charles River Laboratories International Inc. (CRL) News on November 23, 2024

CRL

Argus Research

9 days ago

Market Digest: APA, CBRL, CRL, DUK, SWKS, WWW, HUBS

CRL

Argus Research

9 days ago

Analyst Report: Charles River Laboratories Int

CRL

MT Newswires

11 days ago

Charles River Laboratories International Insider Sold Shares Worth $1,647,418, According to a Recent SEC Filing

CRL

MT Newswires

12 days ago

TD Cowen Adjusts Price Target on Charles River Laboratories International to $227 From $203, Maintains Hold Rating

Charles River (CRL) International Revenue in Focus: Trends and Expectations
CRL

Zacks

12 days ago

Charles River (CRL) International Revenue in Focus: Trends and Expectations

Charles River Laboratories to Present at UBS and Jefferies Conferences
CRL

Business Wire

12 days ago

Charles River Laboratories to Present at UBS and Jefferies Conferences

CRL

MT Newswires

15 days ago

Barrington Adjusts Price Target on Charles River Laboratories International to $212 From $194, Maintains Outperform Rating

Charles River Laboratories International Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
CRL

Simply Wall St.

15 days ago

Charles River Laboratories International Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

CRL

MT Newswires

16 days ago

Morgan Stanley Raises Charles River Laboratories International's Price Target to $225 From $215

CRL

MT Newswires

16 days ago

UBS Adjusts Price Target on Charles River Laboratories International to $250 From $240, Maintains Buy Rating

CRL

MT Newswires

16 days ago

Baird Adjusts Charles River Laboratories International Price Target to $211 From $190, Maintains Neutral Rating

CRL

MT Newswires

16 days ago

JPMorgan Adjusts Charles River Laboratories International Price Target to $215 From $195, Maintains Neutral Rating

CRL

MT Newswires

16 days ago

Evercore ISI Adjusts Charles River Laboratories International Price Target to $225 From $190, Maintains In Line Rating

CRL

Thomson Reuters StreetEvents

16 days ago

Q3 2024 Charles River Laboratories International Inc Earnings Call

CRL

Morningstar Research

16 days ago

Analyst Report: Charles River Laboratories International, Inc.

Charles River Laboratories International Inc (CRL) Q3 2024 Earnings Call Highlights: Navigating ...
CRL

GuruFocus.com

16 days ago

Charles River Laboratories International Inc (CRL) Q3 2024 Earnings Call Highlights: Navigating ...

Decoding Charles River Laboratories International Inc (CRL): A Strategic SWOT Insight
CRL

GuruFocus.com

16 days ago

Decoding Charles River Laboratories International Inc (CRL): A Strategic SWOT Insight

Charles River's Q3 Earnings, Revenues Beat Estimates, Margins Fall
CRL

Zacks

17 days ago

Charles River's Q3 Earnings, Revenues Beat Estimates, Margins Fall

CRL

MT Newswires

17 days ago

Deutsche Bank Raises Charles River Laboratories International Price Target to $250 From $235

Charles River (CRL) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
CRL

Zacks

17 days ago

Charles River (CRL) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

CRL

MT Newswires

17 days ago

Sector Update: Health Care Stocks Advance Pre-Bell Wednesday

Charles River Laboratories (CRL) Q3 Earnings and Revenues Beat Estimates
CRL

Zacks

17 days ago

Charles River Laboratories (CRL) Q3 Earnings and Revenues Beat Estimates

CRL

MT Newswires

17 days ago

Charles River Laboratories Q3 Non-GAAP Earnings, Revenue Decline; 2024 Outlook Lifted

CRL

Associated Press Finance

17 days ago

Charles River: Q3 Earnings Snapshot

Charles River Laboratories Announces Third-Quarter 2024 Results
CRL

Business Wire

17 days ago

Charles River Laboratories Announces Third-Quarter 2024 Results

Gear Up for Charles River (CRL) Q3 Earnings: Wall Street Estimates for Key Metrics
CRL

Zacks

19 days ago

Gear Up for Charles River (CRL) Q3 Earnings: Wall Street Estimates for Key Metrics

Pediatrix Medical Group (MD) Surpasses Q3 Earnings and Revenue Estimates
CRL

Zacks

22 days ago

Pediatrix Medical Group (MD) Surpasses Q3 Earnings and Revenue Estimates

Charles River Laboratories (CRL) Expected to Beat Earnings Estimates: Should You Buy?
CRL

Zacks

24 days ago

Charles River Laboratories (CRL) Expected to Beat Earnings Estimates: Should You Buy?

Why Charles River (CRL) is Poised to Beat Earnings Estimates Again
CRL

Zacks

25 days ago

Why Charles River (CRL) is Poised to Beat Earnings Estimates Again

CRL Gears Up for Q3 Earnings: Here's What You Need to Know
CRL

Zacks

a month ago

CRL Gears Up for Q3 Earnings: Here's What You Need to Know

FibroBiologics and Charles River link for chronic disease therapies manufacture
CRL

Pharmaceutical Technology

a month ago

FibroBiologics and Charles River link for chronic disease therapies manufacture

CRL

MT Newswires

a month ago

FibroBiologics, Charles River Laboratories Team Up to Make Fibroblast-Based Treatments for Chronic Diseases

CRL Stock Gains From New Retrogenix Non-Human Protein Library Launch
CRL

Zacks

a month ago

CRL Stock Gains From New Retrogenix Non-Human Protein Library Launch

Charles River Launches New Retrogenix® Non-Human Protein Library
CRL

Business Wire

a month ago

Charles River Launches New Retrogenix® Non-Human Protein Library

Charles River Laboratories Schedules Third-Quarter 2024 Earnings Release and Conference Call
CRL

Business Wire

a month ago

Charles River Laboratories Schedules Third-Quarter 2024 Earnings Release and Conference Call

CRL

MT Newswires

a month ago

Deutsche Bank Adjusts Charles River Laboratories International Price Target to $235 From $240, Maintains Buy Rating

CRL

MT Newswires

a month ago

Barclays Adjusts Price Target on Charles River Laboratories International to $205 From $210

CRL

MT Newswires

a month ago

JPMorgan Adjusts Charles River Laboratories International Price Target to $195 From $205, Maintains Neutral Rating

CRL

MT Newswires

a month ago

--Redburn Atlantic Initiates Charles River Laboratories International at Sell With $151 Price Target

CRL to Aid Lundbeck's Neurological Drug Research With AI-Backed Logica
CRL

Zacks

a month ago

CRL to Aid Lundbeck's Neurological Drug Research With AI-Backed Logica

CRL

MT Newswires

2 months ago

Goldman Sachs Adjusts Price Target on Charles River Laboratories International to $240 From $250, Maintains Buy Rating

CRL

MT Newswires

2 months ago

Evercore ISI Downgrades Charles River Laboratories International to In Line From Outperform, Adjusts PT to $190 From $225

Charles River Provides Translational Expertise at Neuroscience 2024
CRL

Business Wire

2 months ago

Charles River Provides Translational Expertise at Neuroscience 2024

CRL

MT Newswires

2 months ago

Charles River Laboratories International, Lundbeck Enter Deal for Logica Platform in Brain Disease Research

Charles River and Lundbeck Enter Agreement Utilizing AI-Powered Logica® to Advance the Discovery of Novel Drugs for Neurological Disease
CRL

Business Wire

2 months ago

Charles River and Lundbeck Enter Agreement Utilizing AI-Powered Logica® to Advance the Discovery of Novel Drugs for Neurological Disease

CRL

MT Newswires

2 months ago

BofA Securities Downgrades Charles River Laboratories International to Neutral From Buy on Biopharma Concerns, Price Target is $215

CRL

MT Newswires

2 months ago

Citigroup Downgrades Charles River Laboratories International to Sell From Neutral, Adjusts PT to $175 From $215

Charles River Laboratories International, Inc.'s (NYSE:CRL) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?
CRL

Simply Wall St.

2 months ago

Charles River Laboratories International, Inc.'s (NYSE:CRL) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?

CRL

MT Newswires

2 months ago

Baird Adjusts Charles River Laboratories International Price Target to $190 From $191

CRL Stock to Gain From Strategic Neuroscience Partnership With CEBINA
CRL

Zacks

2 months ago

CRL Stock to Gain From Strategic Neuroscience Partnership With CEBINA

CRL

MT Newswires

2 months ago

Charles River Laboratories, CEBINA Partner to Accelerate Neurodegenerative Drug Development

Charles River Laboratories and CEBINA Announce Strategic Collaboration to Accelerate Cutting Edge Neuroscience Research
CRL

Business Wire

2 months ago

Charles River Laboratories and CEBINA Announce Strategic Collaboration to Accelerate Cutting Edge Neuroscience Research

CRL Stock May Benefit From New Neuroscience Research Collaboration
CRL

Zacks

2 months ago

CRL Stock May Benefit From New Neuroscience Research Collaboration

Why Is Charles River (CRL) Down 5.3% Since Last Earnings Report?
CRL

Zacks

3 months ago

Why Is Charles River (CRL) Down 5.3% Since Last Earnings Report?

Higher Interest Environment Negatively Impacted Charles River Laboratories (CRL)
CRL

Insider Monkey

3 months ago

Higher Interest Environment Negatively Impacted Charles River Laboratories (CRL)

CRL

MT Newswires

3 months ago

Charles River Laboratories, Insightec Collaborate on Focused Ultrasound in Neuroscience

Charles River and Insightec Announce Strategic Collaboration to Advance Therapeutic Development Utilizing Focused Ultrasound in Neuroscience
CRL

Business Wire

3 months ago

Charles River and Insightec Announce Strategic Collaboration to Advance Therapeutic Development Utilizing Focused Ultrasound in Neuroscience

Charles River Laboratories to Present at Baird and Morgan Stanley Conferences
CRL

Business Wire

3 months ago

Charles River Laboratories to Present at Baird and Morgan Stanley Conferences

Calculating The Intrinsic Value Of Charles River Laboratories International, Inc. (NYSE:CRL)
CRL

Simply Wall St.

3 months ago

Calculating The Intrinsic Value Of Charles River Laboratories International, Inc. (NYSE:CRL)

Charles River Laboratories International (CRL) Fell Due to a More Cautious Funding Environment
CRL

Insider Monkey

3 months ago

Charles River Laboratories International (CRL) Fell Due to a More Cautious Funding Environment

Terumo and Charles River demonstrate effectiveness of CGT manufacturing device
CRL

Medical Device Network

3 months ago

Terumo and Charles River demonstrate effectiveness of CGT manufacturing device

CRL

Argus Research

3 months ago

Analyst Report: Charles River Laboratories Int

CRL

Argus Research

3 months ago

Market Digest: CRL, DE, EBAY, ES, PH, WWW

CRL

MT Newswires

3 months ago

Mizuho Adjusts Price Target on Charles River Laboratories International to $210 From $235, Maintains Neutral Rating

Insider Sale: EVP Joseph Laplume Sells Shares of Charles River Laboratories International Inc (CRL)
CRL

GuruFocus.com

3 months ago

Insider Sale: EVP Joseph Laplume Sells Shares of Charles River Laboratories International Inc (CRL)

CRL

MT Newswires

3 months ago

Charles River Laboratories International Insider Sold Shares Worth $354,861, According to a Recent SEC Filing

CRL

MT Newswires

3 months ago

TD Cowen Adjusts Price Target on Charles River Laboratories International to $203 From $228, Maintains Hold

Why Charles River (CRL) International Revenue Trends Deserve Your Attention
CRL

Zacks

3 months ago

Why Charles River (CRL) International Revenue Trends Deserve Your Attention

Analysts Have Lowered Expectations For Charles River Laboratories International, Inc. (NYSE:CRL) After Its Latest Results
CRL

Simply Wall St.

3 months ago

Analysts Have Lowered Expectations For Charles River Laboratories International, Inc. (NYSE:CRL) After Its Latest Results

CRL

Morningstar Research

3 months ago

Analyst Report: Charles River Laboratories International, Inc.

CRL

MT Newswires

3 months ago

Morgan Stanley Cuts Price Target on Charles River Laboratories International to $215 From $235

CRL

MT Newswires

3 months ago

Stephens Adjusts Price Target on Charles River Laboratories International to $240 From $250

CRL

MT Newswires

3 months ago

UBS Adjusts Charles River Laboratories International Price Target to $240 From $290, Maintains Buy Rating

CRL

MT Newswires

3 months ago

Jefferies Adjusts Price Target on Charles River Laboratories International to $196 From $226

CRL

MT Newswires

3 months ago

Citigroup Adjusts Price Target on Charles River Laboratories International to $215 From $250

CRL

MT Newswires

3 months ago

Barclays Adjusts Price Target on Charles River Laboratories International to $210 From $230

CRL

MT Newswires

3 months ago

Goldman Sachs Adjusts Price Target on Charles River Laboratories International to $250 From $290

CRL

MT Newswires

3 months ago

Baird Downgrades Charles River Laboratories International to Neutral From Outperform, Adjusts PT to $191 From $239

CRL

MT Newswires

3 months ago

JPMorgan Downgrades Charles River Laboratories International to Neutral From Overweight, Adjusts PT to $205 From $270

Big Pharma Cuts R&D, Sending Shudders Through Industry
CRL

The Wall Street Journal

3 months ago

Big Pharma Cuts R&D, Sending Shudders Through Industry

Decoding Charles River Laboratories International Inc (CRL): A Strategic SWOT Insight
CRL

GuruFocus.com

3 months ago

Decoding Charles River Laboratories International Inc (CRL): A Strategic SWOT Insight

CRL

Thomson Reuters StreetEvents

3 months ago

Q2 2024 Charles River Laboratories International Inc Earnings Call

CRL

Morningstar Research

4 months ago

Analyst Report: Charles River Laboratories International, Inc.

S&P 500 Gains and Losses Today: Fortinet Stock Surges on Earnings Beat
CRL

Investopedia

4 months ago

S&P 500 Gains and Losses Today: Fortinet Stock Surges on Earnings Beat

Charles River (CRL) Q2 Earnings Beat Estimates, 2024 View Down
CRL

Zacks

4 months ago

Charles River (CRL) Q2 Earnings Beat Estimates, 2024 View Down

Charles River Labs Says It Expects Sales To Fall, Sending Its Stock Tumbling
CRL

Investopedia

4 months ago

Charles River Labs Says It Expects Sales To Fall, Sending Its Stock Tumbling

CRL

MT Newswires

4 months ago

Deutsche Bank Adjusts Price Target on Charles River Laboratories International to $240 From $300

Here's What Key Metrics Tell Us About Charles River (CRL) Q2 Earnings
CRL

Zacks

4 months ago

Here's What Key Metrics Tell Us About Charles River (CRL) Q2 Earnings

Charles River Labs Plummets 17% On 'Bleaker' Expectations For 2024
CRL

Investor's Business Daily

4 months ago

Charles River Labs Plummets 17% On 'Bleaker' Expectations For 2024

Charles River Laboratories (CRL) Surpasses Q2 Earnings and Revenue Estimates
CRL

Zacks

4 months ago

Charles River Laboratories (CRL) Surpasses Q2 Earnings and Revenue Estimates

CRL

MT Newswires

4 months ago

Charles River Laboratories' Q2 Non-GAAP Earnings Rise, Revenue Falls; 2024 Outlook Slashed

CRL

Associated Press Finance

4 months ago

Charles River: Q2 Earnings Snapshot

Charles River Laboratories Announces Second-Quarter 2024 Results
CRL

Business Wire

4 months ago

Charles River Laboratories Announces Second-Quarter 2024 Results

Unlocking Q2 Potential of Charles River (CRL): Exploring Wall Street Estimates for Key Metrics
CRL

Zacks

4 months ago

Unlocking Q2 Potential of Charles River (CRL): Exploring Wall Street Estimates for Key Metrics

CRL

Morningstar Research

4 months ago

Analyst Report: Charles River Laboratories International, Inc.

Charles River Collaborates with Patient Advocacy Group, FOXG1 Research Foundation to Advance Rare Disease Gene Therapy Development
CRL

Business Wire

4 months ago

Charles River Collaborates with Patient Advocacy Group, FOXG1 Research Foundation to Advance Rare Disease Gene Therapy Development

CRL

MT Newswires

4 months ago

Charles River Laboratories Invests in Autobahn Labs Under Collaborative Deal

Here's How Charles River (CRL) is Placed Ahead of Q2 Earnings
CRL

Zacks

4 months ago

Here's How Charles River (CRL) is Placed Ahead of Q2 Earnings

Charles River Laboratories and Autobahn Labs Announce Collaborative Program to Accelerate Academic Drug Discovery
CRL

Business Wire

4 months ago

Charles River Laboratories and Autobahn Labs Announce Collaborative Program to Accelerate Academic Drug Discovery

Charles River Laboratories Schedules Second-Quarter 2024 Earnings Release and Conference Call
CRL

Business Wire

4 months ago

Charles River Laboratories Schedules Second-Quarter 2024 Earnings Release and Conference Call

Share on Social Networks: